Use of ‘very low-dose phenobarbital’ to investigate compliance in patients on reducing doses of methadone (detoxification)
- 31 October 1993
- journal article
- editorial
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 10 (5) , 453-458
- https://doi.org/10.1016/0740-5472(93)90006-n
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A comparison of a short half‐life marker (low‐dose isoniazid), a long half‐life pharmacological indicator (low‐dose phenobarbitone) and measurements of a controlled release ‘therapeutic drug’ (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.British Journal of Clinical Pharmacology, 1990
- Time to stop counting the tablets?Clinical Pharmacology & Therapeutics, 1989
- Opiate Withdrawal Symptoms in Response to 10-Day and 21-Day Methadone Withdrawal ProgrammesThe British Journal of Psychiatry, 1989
- Effects of Information on the Opiate Withdrawal SyndromeBritish Journal of Addiction, 1988
- Tapering from methadone maintenance: Attitudes of clients and staffJournal of Substance Abuse Treatment, 1988
- Low‐dose phenobarbitone as an indicator of compliance with drug therapy.British Journal of Clinical Pharmacology, 1987
- An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedureAddictive Behaviors, 1986
- The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.British Journal of Clinical Pharmacology, 1986
- Detoxification of rehabilitated methadone-maintained patientsPublished by American Medical Association (AMA) ,1973